Article may be outdated

This article is 8 days old. Some details may have changed since publication.

ABC News & Headlines – Australian Broadcasting Corporation·3 min read·medium

like drugs with poor heart health outcomes

L
Lauren Roberts
like drugs with poor heart health outcomes
✦AI Summary

A study of 80,000 Italian patients suggests that stopping GLP-1 medications like Ozempic may be linked to an increased risk of heart attack, stroke, or death. However, experts caution that the study does not prove causation and lacks data on why patients discontinued the treatment.

Why it matters

As GLP-1 drugs become widely used for diabetes and weight loss, understanding the long-term risks of discontinuation is critical for patient safety and clinical guidance.

✦Dive DeeperCreate a free account to unlock

Researchers say we do not have enough long-term data about GLP-1 medications. ( Getty Images: brizmaker )

A large study suggests people with type 2 diabetes who start and then stop GLP-1 drugs may have poorer health outcomes.

But Australian experts say more information is needed to support this conclusion.

The study highlights the importance for people taking these medications to work closely with their doctor, experts say, especially if wanting to ease off the drugs.

Link copied Share Share article People with type 2 diabetes who start and then stop using GLP-1 medications may face an increased risk of heart attack, stroke or death than those who keep using them, according to a new international study.

But Australian experts urge caution interpreting the findings, with the study unable to prove causation and no data collected about why people stopped using the drug.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in